Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Indivior PLC (LON:INDV) (NASDAQ:INDV), a pharmaceutical company with a market capitalization of $2.9 billion and an "GREAT" overall financial health score according to InvestingPro, announced Wednesday that it entered into a new employment agreement and a new confidentiality, proprietary rights, and non-competition agreement with Chief Financial Officer Ryan Preblick. The agreements, effective August 20, align Preblick’s terms with the company’s current forms used for U.S.-based executives.
According to a press release statement included in the company’s SEC filing, Preblick’s compensation, responsibilities, and title remain unchanged under the new agreements. His annual base salary is $558,819, and he is eligible for an annual cash bonus targeted at 60% of base salary, with a maximum opportunity up to 120%, dependent on individual and company performance. The agreements also provide for potential annual long-term incentive awards with a grant-date value anticipated at 400% of base salary, subject to the discretion of the company’s compensation committee.
Preblick’s previous agreement dated from 2020. The company stated the new agreements are intended to update his terms in line with current executive contracts.
The information is based on a press release statement included in Indivior’s recent SEC filing. Indivior’s ordinary shares are listed on the Nasdaq Stock Market under the symbol INDV.
In other recent news, Indivior PLC reported a notable earnings beat for the second quarter of 2025. The company achieved earnings per share of $0.51, significantly surpassing the forecasted $0.24, marking an impressive 112.5% increase. Indivior’s revenue also exceeded expectations, reaching $302 million, which is a 24.96% rise above projections. These figures indicate strong financial performance for the company in the recent quarter. Additionally, following the earnings announcement, there was notable investor optimism. Analysts and investors closely monitored these results, considering them a positive indicator of the company’s current financial health. These developments are part of the latest updates concerning Indivior PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.